Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial". Bleeding, Thrombosis and Vascular Biology, [S. l.], v. 4, n. 2, 2025. DOI: 10.4081/btvb.2025.179. Disponível em: https://www.btvb.org/btvb/article/view/179. Acesso em: 6 jun. 2025.